Sign in

CIK 0001253689

  • Non-accelerated filer
  • Smaller reporting company

CRESCENT BIOPHARMA, INC.

Sign in to watch
Ticker
CBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
Phone
+1 617-430-5595
Business address
300 FIFTH AVENUE, WALTHAM, MA, 02451
Former names
GLYCOMIMETICS INC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Other acquisition 10% owner acquired 1,270,004 shares (other)
  12. 4 Open-market sale 10% owner sold 322,361 shares at an average $0.19 ($61,206)
  13. 4 Open-market sale 10% owner sold 220,255 shares at an average $0.19 ($41,184)
  14. 4 Open-market sale 10% owner sold 349,764 shares at an average $0.20 ($71,097)
  15. 4 Open-market sale 10% owner sold 1,379,119 shares at an average $0.23 ($315,262)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Chief Medical Officer bought 305,000 shares at an average $0.26 ($78,825)
  18. 4 Open-market buy SVP Finance, CFO bought 17,500 shares at $0.25 ($4,335)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 15 · 293 filings